Page 46 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
CID 3717. Myocardial Wall Segments ..................................................................................................................... |
|
661 |
CID 3718. Myocardial Wall Segments in Projection .................................................................................................... |
661 |
|
CID 3719. Canadian Clinical Classification ............................................................................................................... |
662 |
|
CID 3721. Cardiovascular Surgeries ....................................................................................................................... |
|
662 |
CID 3722. Diabetic Therapy .................................................................................................................................. |
|
663 |
CID 3723. MI Types ............................................................................................................................................ |
|
663 |
CID 3724. Smoking History ................................................................................................................................... |
|
663 |
CID 3726. Indications for Coronary Intervention ........................................................................................................ |
664 |
|
CID 3727. Indications for Catheterization ................................................................................................................. |
664 |
|
CID 3728. Cath Findings ...................................................................................................................................... |
|
665 |
CID 3729. Admission Status ................................................................................................................................. |
|
666 |
CID 3730. Insurance Payor ................................................................................................................................... |
|
666 |
CID 3733. Primary Cause of Death ......................................................................................................................... |
|
667 |
CID 3735. Acute Coronary Syndrome Time Period .................................................................................................... |
667 |
|
CID 3736. NYHA Classification .............................................................................................................................. |
|
667 |
CID 3737. Non-invasive Test - Ischemia .................................................................................................................. |
668 |
|
CID 3738. Pre-Cath Angina Type ........................................................................................................................... |
|
668 |
CID 3739. Cath Procedure Type ............................................................................................................................ |
|
668 |
CID 3740. Thrombolytic Administration .................................................................................................................... |
|
669 |
CID 3741. Medication Administration, Lab Visit ......................................................................................................... |
669 |
|
CID 3742. Medication Administration, PCI ................................................................................................................ |
669 |
|
CID 3743. Clopidogrel/Ticlopidine Administration ...................................................................................................... |
670 |
|
CID 3744. EF Testing Method ............................................................................................................................... |
|
670 |
CID 3745. Calculation Method ............................................................................................................................... |
|
670 |
CID 3746. Percutaneous Entry Site ........................................................................................................................ |
|
671 |
CID 3747. Percutaneous Closure ........................................................................................................................... |
|
671 |
CID 3748. Angiographic EF Testing Method ............................................................................................................. |
671 |
|
CID 3749. PCI Procedure Result ............................................................................................................................ |
|
672 |
CID 3750. Previously Dilated Lesion ....................................................................................................................... |
|
672 |
CID 3752. Guidewire Crossing .............................................................................................................................. |
|
672 |
CID 3754. Vascular Complications ......................................................................................................................... |
|
672 |
CID 3755. Cath Complications ............................................................................................................................... |
|
673 |
CID 3756. Cardiac Patient Risk Factors |
................................................................................................................... |
673 |
CID 3757. Cardiac Diagnostic Procedures ............................................................................................................... |
674 |
|
CID 3758. Cardiovascular Family History ................................................................................................................. |
675 |
|
CID 3760. Hypertension Therapy ........................................................................................................................... |
|
675 |
CID 3761. Antilipemic Agents ................................................................................................................................ |
|
676 |
CID 3762. Antiarrhythmic Agents ........................................................................................................................... |
|
676 |
CID 3764. Myocardial Infarction Therapies ............................................................................................................... |
677 |
|
CID 3769. Concern Types .................................................................................................................................... |
|
677 |
CID 3770. Problem Status .................................................................................................................................... |
|
677 |
CID 3772. Health Status ....................................................................................................................................... |
|
678 |
CID 3773. Use Status .......................................................................................................................................... |
|
678 |
CID 3774. Social History ...................................................................................................................................... |
|
678 |
CID 3777. Implanted Devices ................................................................................................................................ |
|
679 |
CID 3778. Stages ............................................................................................................................................... |
|
679 |
CID 3802. Plaque Structures ................................................................................................................................. |
|
679 |
CID 3804. Stenosis Measurement Methods .............................................................................................................. |
680 |
|
CID 3805. Stenosis Types .................................................................................................................................... |
|
680 |
CID 3806. Stenosis Shape .................................................................................................................................... |
|
681 |
CID 3807. Volume Measurement Methods ............................................................................................................... |
681 |
|
CID 3808. Aneurysm Types .................................................................................................................................. |
|
681 |
CID 3809. Associated Conditions ........................................................................................................................... |
|
682 |
CID 3810. Vascular Morphology ............................................................................................................................ |
|
682 |
CID 3813. Stent Findings ..................................................................................................................................... |
|
683 |
CID 3814. Stent Composition ................................................................................................................................ |
|
683 |
CID 3815. Source of Vascular Finding ..................................................................................................................... |
|
683 |
CID 3817. Vascular Sclerosis Types ....................................................................................................................... |
|
684 |
CID 3820. Non-invasive Vascular Procedures ........................................................................................................... |
684 |
|
CID 3821. Papillary Muscle Included/Excluded ......................................................................................................... |
685 |
|
- Standard -
DICOM PS3.16 2020a - Content Mapping Resource |
Page 47 |
CID 3823. Respiratory Status ................................................................................................................................ |
685 |
CID 3826. Heart Rhythm ...................................................................................................................................... |
685 |
CID 3827. Vessel Segments ................................................................................................................................. |
685 |
CID 3829. Pulmonary Arteries ............................................................................................................................... |
686 |
CID 3831. Stenosis Length ................................................................................................................................... |
686 |
CID 3832. Stenosis Grade .................................................................................................................................... |
687 |
CID 3833. Cardiac Ejection Fraction ....................................................................................................................... |
687 |
CID 3835. Cardiac Volume Measurements ............................................................................................................... |
687 |
CID 3836. Time-based Perfusion Measurements ....................................................................................................... |
687 |
CID 3837. Fiducial Feature ................................................................................................................................... |
688 |
CID 3838. Diameter Derivation .............................................................................................................................. |
688 |
CID 3839. Coronary Veins .................................................................................................................................... |
688 |
CID 3840. Pulmonary Veins .................................................................................................................................. |
689 |
CID 3843. Myocardial Subsegment ........................................................................................................................ |
689 |
CID 3850. Contrast Bolus Substance ...................................................................................................................... |
690 |
CID 4005. Partial View Section for Mammography ..................................................................................................... |
690 |
CID 4009. DX Anatomy Imaged ............................................................................................................................. |
690 |
CID 4010. DX View ............................................................................................................................................. |
691 |
CID 4011. DX View Modifier .................................................................................................................................. |
692 |
CID 4012. Projection Eponymous Name .................................................................................................................. |
693 |
CID 4013. Anatomic Region for Mammography ......................................................................................................... |
695 |
CID 4014. View for Mammography ......................................................................................................................... |
696 |
CID 4015. View Modifier for Mammography ............................................................................................................. |
696 |
CID 4016. Anatomic Region for Intra-oral Radiography ............................................................................................... |
697 |
CID 4017. Anatomic Region Modifier for Intra-oral Radiography ................................................................................... |
698 |
CID 4018. Primary Anatomic Structure for Intra-oral Radiography (Permanent Dentition - Designation of Teeth) .................... |
698 |
CID 4019. Primary Anatomic Structure for Intra-oral Radiography (Deciduous Dentition - Designation of Teeth) ..................... |
700 |
CID 4020. PET Radionuclide ................................................................................................................................. |
701 |
CID 4021. PET Radiopharmaceutical ...................................................................................................................... |
702 |
CID 4025. Primary Anatomic Structure for Intra-oral Radiography (Supernumerary Dentition - Designation of Teeth) .............. |
706 |
CID 4026. Primary Anatomic Structure for Intra-oral and Craniofacial Radiography - Teeth ................................................ |
708 |
CID 4028. Craniofacial Anatomic Regions ................................................................................................................ |
708 |
CID 4029. Dermatology Anatomic Sites ................................................................................................................... |
710 |
CID 4030. CT, MR and PET Anatomy Imaged .......................................................................................................... |
719 |
CID 4031. Common Anatomic Regions ................................................................................................................... |
720 |
CID 4032. MR Spectroscopy Metabolites ................................................................................................................. |
723 |
CID 4033. MR Proton Spectroscopy Metabolites ....................................................................................................... |
723 |
CID 4040. Endoscopy Anatomic Regions ................................................................................................................. |
724 |
CID 4042. XA/XRF Anatomy Imaged ...................................................................................................................... |
725 |
CID 4050. Drug or Contrast Agent Characteristics ..................................................................................................... |
726 |
CID 4051. General Devices .................................................................................................................................. |
726 |
CID 4052. Phantom Devices ................................................................................................................................. |
726 |
CID 4100. T1 Measurement Methods ...................................................................................................................... |
727 |
CID 4101. Tracer Kinetic Models ............................................................................................................................ |
727 |
CID 4102. Perfusion Measurement Methods ............................................................................................................ |
727 |
CID 4103. Arterial Input Function Measurement Methods ............................................................................................ |
728 |
CID 4104. Bolus Arrival Time Derivation Methods ...................................................................................................... |
728 |
CID 4105. Perfusion Analysis Methods .................................................................................................................... |
728 |
CID 4106. Quantitative Methods used for Perfusion And Tracer Kinetic Models ............................................................... |
729 |
CID 4107. Tracer Kinetic Model Parameters ............................................................................................................. |
729 |
CID 4108. Perfusion Model Parameters ................................................................................................................... |
729 |
CID 4109. Model-Independent Dynamic Contrast Analysis Parameters .......................................................................... |
730 |
CID 4110. Tracer Kinetic Modeling Covariates .......................................................................................................... |
731 |
CID 4111. Contrast Characteristics ......................................................................................................................... |
731 |
CID 4200. Ophthalmic Imaging Agent ..................................................................................................................... |
732 |
CID 4201. Patient Eye Movement Command ............................................................................................................ |
732 |
CID 4202. Ophthalmic Photography Acquisition Device .............................................................................................. |
732 |
CID 4203. Ophthalmic Photography Illumination ........................................................................................................ |
733 |
CID 4204. Ophthalmic Filter .................................................................................................................................. |
734 |
CID 4205. Ophthalmic Lens .................................................................................................................................. |
734 |
- Standard -
Page 48 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
CID 4206. Ophthalmic Channel Description .............................................................................................................. |
734 |
|
CID 4207. Ophthalmic Image Position ..................................................................................................................... |
|
735 |
CID 4208. Mydriatic Agent .................................................................................................................................... |
|
736 |
CID 4209. Ophthalmic Anatomic Structure Imaged .................................................................................................... |
736 |
|
CID 4210. Ophthalmic Tomography Acquisition Device .............................................................................................. |
737 |
|
CID 4211. Ophthalmic OCT Anatomic Structure Imaged ............................................................................................. |
737 |
|
CID 4214. Ophthalmic Horizontal Directions ............................................................................................................. |
738 |
|
CID 4215. Ophthalmic Vertical Directions ................................................................................................................ |
738 |
|
CID 4216. Ophthalmic Visual Acuity Type ................................................................................................................ |
738 |
|
CID 4220. Visual Fixation Quality During Acquisition .................................................................................................. |
738 |
|
CID 4221. Visual Fixation Quality Problem ............................................................................................................... |
739 |
|
CID 4222. Ophthalmic Macular Grid Problem ........................................................................................................... |
739 |
|
CID 4230. Ophthalmic Ultrasound Axial Measurements Type ....................................................................................... |
740 |
|
CID 4231. Lens Status ......................................................................................................................................... |
|
740 |
CID 4232. Vitreous Status .................................................................................................................................... |
|
740 |
CID 4233. Ophthalmic Axial Length Measurements Segment Names ............................................................................ |
740 |
|
CID 4234. Refractive Surgery Types ....................................................................................................................... |
|
741 |
CID 4235. Keratometry Descriptors ........................................................................................................................ |
|
741 |
CID 4236. IOL Calculation Formula ........................................................................................................................ |
|
741 |
CID 4237. Lens Constant Type .............................................................................................................................. |
|
742 |
CID 4238. Refractive Error Types ........................................................................................................................... |
|
742 |
CID 4239. Anterior Chamber Depth Definition ........................................................................................................... |
743 |
|
CID 4240. Ophthalmic Measurement or Calculation Data Source .................................................................................. |
743 |
|
CID 4241. Ophthalmic Axial Length Selection Method ................................................................................................ |
743 |
|
CID 4242. Cornea Measurement Method Descriptors ................................................................................................. |
743 |
|
CID 4243. Ophthalmic Quality Metric Type ............................................................................................................... |
744 |
|
CID 4244. Ophthalmic Agent Concentration Units ...................................................................................................... |
744 |
|
CID 4245. Wide Field Ophthalmic Photography Transformation Method ......................................................................... |
744 |
|
CID 4250. Visual Field Static Perimetry Test Patterns ................................................................................................ |
744 |
|
CID 4251. Visual Field Static Perimetry Test Strategies .............................................................................................. |
745 |
|
CID 4252. Visual Field Static Perimetry Screening Test Modes .................................................................................... |
746 |
|
CID 4253. Visual Field Static Perimetry Fixation Strategy ............................................................................................ |
746 |
|
CID 4254. Visual Field Static Perimetry Test Analysis Results ...................................................................................... |
746 |
|
CID 4255. Visual Field Illumination Color ................................................................................................................. |
747 |
|
CID 4256. Visual Field Procedure Modifier ............................................................................................................... |
747 |
|
CID 4257. Visual Field Global Index Name ............................................................................................................... |
747 |
|
CID 4260. Ophthalmic Mapping Units for Real World Value Mapping ............................................................................. |
748 |
|
CID 4261. Ophthalmic Mapping Acquisition Method ................................................................................................... |
748 |
|
CID 4262. Retinal Thickness Definition .................................................................................................................... |
|
748 |
CID 4263. Ophthalmic Thickness Map Value Type .................................................................................................... |
748 |
|
CID 4264. Ophthalmic Map Purposes of Reference ................................................................................................... |
749 |
|
CID 4265. Ophthalmic Thickness Deviation Categories .............................................................................................. |
749 |
|
CID 4266. Ophthalmic Anatomic Structure Reference Point ......................................................................................... |
749 |
|
CID 4267. Corneal Topography Mapping Units for Real World Value Mapping ................................................................ |
750 |
|
CID 4268. Corneal Topography Map Value Type ....................................................................................................... |
750 |
|
CID 4270. OCT-A Processing Algorithm Families ...................................................................................................... |
750 |
|
CID 4271. En Face Image Types ........................................................................................................................... |
|
751 |
CID 4272. OPT Scan Pattern Types ....................................................................................................................... |
|
751 |
CID 4273. Retinal Segmentation Surfaces ............................................................................................................... |
752 |
|
CID 6000. Overall Breast Composition .................................................................................................................... |
|
753 |
CID 6001. Overall Breast Composition from BI-RADS® .............................................................................................. |
753 |
|
CID 6002. Change Since Last Mammogram or Prior Surgery ....................................................................................... |
754 |
|
CID 6003. Change Since Last Mammogram or Prior Surgery from BI-RADS® ................................................................. |
754 |
|
CID 6004. Mammography Characteristics of Shape ................................................................................................... |
755 |
|
CID 6005. Characteristics of Shape from BI-RADS® .................................................................................................. |
755 |
|
CID 6006. Mammography Characteristics of Margin ................................................................................................... |
755 |
|
CID 6007. Characteristics of Margin from BI-RADS® ................................................................................................. |
756 |
|
CID 6008. Density Modifier ................................................................................................................................... |
|
756 |
CID 6009. Density Modifier from BI-RADS® ............................................................................................................. |
756 |
|
CID 6010. Mammography Calcification Types ........................................................................................................... |
757 |
|
- Standard -
DICOM PS3.16 2020a - Content Mapping Resource |
Page 49 |
CID 6011. Calcification Types from BI-RADS® ......................................................................................................... |
757 |
CID 6012. Calcification Distribution Modifier ............................................................................................................. |
758 |
CID 6013. Calcification Distribution Modifier from BI-RADS® ....................................................................................... |
758 |
CID 6014. Mammography Single Image Finding ........................................................................................................ |
758 |
CID 6015. Single Image Finding from BI-RADS® ...................................................................................................... |
759 |
CID 6016. Mammography Composite Feature .......................................................................................................... |
759 |
CID 6017. Composite Feature from BI-RADS® ......................................................................................................... |
760 |
CID 6018. Clockface Location or Region ................................................................................................................. |
760 |
CID 6019. Clockface Location or Region from BI-RADS® ........................................................................................... |
760 |
CID 6020. Quadrant Location ................................................................................................................................ |
761 |
CID 6021. Quadrant Location from BI-RADS® .......................................................................................................... |
761 |
CID 6022. Side ................................................................................................................................................... |
762 |
CID 6023. Side from BI-RADS® ............................................................................................................................ |
762 |
CID 6024. Depth ................................................................................................................................................. |
762 |
CID 6025. Depth from BI-RADS® .......................................................................................................................... |
763 |
CID 6026. Mammography Assessment ................................................................................................................... |
763 |
CID 6027. Assessment from BI-RADS® .................................................................................................................. |
763 |
CID 6028. Mammography Recommended Follow-up .................................................................................................. |
764 |
CID 6029. Recommended Follow-up from BI-RADS® ................................................................................................ |
764 |
CID 6030. Mammography Pathology Codes ............................................................................................................. |
765 |
CID 6031. Benign Pathology Codes from BI-RADS® ................................................................................................. |
766 |
CID 6032. High Risk Lesions Pathology Codes from BI-RADS® ................................................................................... |
768 |
CID 6033. Malignant Pathology Codes from BI-RADS® .............................................................................................. |
768 |
CID 6034. Intended Use of CAD Output .................................................................................................................. |
770 |
CID 6035. Composite Feature Relations .................................................................................................................. |
770 |
CID 6036. Scope of Feature .................................................................................................................................. |
771 |
CID 6037. Mammography Quantitative Temporal Difference Type ................................................................................ |
771 |
CID 6038. Mammography Qualitative Temporal Difference Type .................................................................................. |
771 |
CID 6039. Nipple Characteristic ............................................................................................................................. |
772 |
CID 6040. Non-lesion Object Type ......................................................................................................................... |
772 |
CID 6041. Mammography Image Quality Finding ....................................................................................................... |
772 |
CID 6042. Status of Results .................................................................................................................................. |
774 |
CID 6043. Types of Mammography CAD Analysis ..................................................................................................... |
774 |
CID 6044. Types of Image Quality Assessment ......................................................................................................... |
774 |
CID 6045. Mammography Types of Quality Control Standard ....................................................................................... |
775 |
CID 6046. Units of Follow-up Interval ...................................................................................................................... |
775 |
CID 6047. CAD Processing and Findings Summary ................................................................................................... |
775 |
CID 6048. CAD Operating Point Axis Label .............................................................................................................. |
776 |
CID 6050. Breast Procedure Reported .................................................................................................................... |
776 |
CID 6051. Breast Procedure Reason ...................................................................................................................... |
777 |
CID 6052. Breast Imaging Report Section Title ......................................................................................................... |
778 |
CID 6053. Breast Imaging Report Elements ............................................................................................................. |
779 |
CID 6054. Breast Imaging Findings ........................................................................................................................ |
779 |
CID 6055. Breast Clinical Finding or Indicated Problem .............................................................................................. |
779 |
CID 6056. Associated Findings for Breast ................................................................................................................ |
780 |
CID 6057. Ductography Findings for Breast .............................................................................................................. |
781 |
CID 6058. Procedure Modifiers for Breast ................................................................................................................ |
781 |
CID 6059. Breast Implant Types ............................................................................................................................ |
781 |
CID 6060. Breast Biopsy Techniques ...................................................................................................................... |
782 |
CID 6061. Breast Imaging Procedure Modifiers ......................................................................................................... |
783 |
CID 6062. Interventional Procedure Complications .................................................................................................... |
783 |
CID 6063. Interventional Procedure Results ............................................................................................................. |
783 |
CID 6064. Ultrasound Findings for Breast ................................................................................................................ |
784 |
CID 6065. Instrument Approach ............................................................................................................................. |
784 |
CID 6066. Target Confirmation .............................................................................................................................. |
785 |
CID 6067. Fluid Color .......................................................................................................................................... |
785 |
CID 6068. Tumor Stages From AJCC ..................................................................................................................... |
786 |
CID 6069. Nottingham Combined Histologic Grade .................................................................................................... |
786 |
CID 6070. Bloom-Richardson Histologic Grade ......................................................................................................... |
786 |
CID 6071. Histologic Grading Method ..................................................................................................................... |
787 |
- Standard -
Page 50 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
CID 6072. Breast Implant Findings ......................................................................................................................... |
|
787 |
CID 6080. Gynecological Hormones ....................................................................................................................... |
|
787 |
CID 6081. Breast Cancer Risk Factors .................................................................................................................... |
|
788 |
CID 6082. Gynecological Procedures ...................................................................................................................... |
|
789 |
CID 6083. Procedures for Breast ........................................................................................................................... |
|
789 |
CID 6084. Mammoplasty Procedures ...................................................................................................................... |
|
789 |
CID 6085. Therapies for Breast ............................................................................................................................. |
|
789 |
CID 6086. Menopausal Phase ............................................................................................................................... |
|
790 |
CID 6087. General Risk Factors ............................................................................................................................ |
|
790 |
CID 6088. OB-GYN Maternal Risk Factors ............................................................................................................... |
790 |
|
CID 6089. Substances ......................................................................................................................................... |
|
791 |
CID 6090. Relative Usage, Exposure Amount ........................................................................................................... |
792 |
|
CID 6091. Relative Frequency of Event Values ......................................................................................................... |
792 |
|
CID 6092. Quantitative Concepts for Usage, Exposure ............................................................................................... |
792 |
|
CID 6093. Qualitative Concepts for Usage, Exposure Amount ...................................................................................... |
793 |
|
CID 6094. Qualitative Concepts for Usage, Exposure Frequency .................................................................................. |
793 |
|
CID 6095. Numeric Properties of Procedures ........................................................................................................... |
793 |
|
CID 6096. Pregnancy Status ................................................................................................................................. |
|
793 |
CID 6097. Side of Family ...................................................................................................................................... |
|
794 |
CID 6098. Clinical Course of Disease ..................................................................................................................... |
|
794 |
CID 6099. Racial Group ....................................................................................................................................... |
|
794 |
CID 6100. Chest Component Categories ................................................................................................................. |
795 |
|
CID 6101. Chest Finding or Feature ....................................................................................................................... |
|
795 |
CID 6102. Chest Finding or Feature Modifier ............................................................................................................ |
795 |
|
CID 6103. Abnormal Lines Finding or Feature .......................................................................................................... |
796 |
|
CID 6104. Abnormal Opacity Finding or Feature ....................................................................................................... |
796 |
|
CID 6105. Abnormal Lucency Finding or Feature ...................................................................................................... |
797 |
|
CID 6106. Abnormal Texture Finding or Feature ....................................................................................................... |
798 |
|
CID 6107. Width Descriptor .................................................................................................................................. |
|
798 |
CID 6108. Chest Anatomic Structure Abnormal Distribution ......................................................................................... |
798 |
|
CID 6109. Radiographic Anatomy Finding or Feature ................................................................................................. |
799 |
|
CID 6110. Lung Anatomy Finding or Feature ............................................................................................................ |
799 |
|
CID 6111. Bronchovascular Anatomy Finding or Feature ............................................................................................ |
800 |
|
CID 6112. Pleura Anatomy Finding or Feature .......................................................................................................... |
800 |
|
CID 6113. Mediastinum Anatomy Finding or Feature .................................................................................................. |
801 |
|
CID 6114. Osseous Anatomy Finding or Feature ....................................................................................................... |
802 |
|
CID 6115. Osseous Anatomy Modifiers |
................................................................................................................... |
802 |
CID 6116. Muscular Anatomy ................................................................................................................................ |
|
803 |
CID 6117. Vascular Anatomy ................................................................................................................................ |
|
804 |
CID 6118. Size Descriptor .................................................................................................................................... |
|
805 |
CID 6119. Chest Border Shape ............................................................................................................................. |
|
806 |
CID 6120. Chest Border Definition .......................................................................................................................... |
|
806 |
CID 6121. Chest Orientation Descriptor |
................................................................................................................... |
806 |
CID 6122. Chest Content Descriptor ....................................................................................................................... |
|
807 |
CID 6123. Chest Opacity Descriptor ....................................................................................................................... |
|
807 |
CID 6124. Location in Chest ................................................................................................................................. |
|
807 |
CID 6125. General Chest Location ......................................................................................................................... |
|
808 |
CID 6126. Location in Lung ................................................................................................................................... |
|
808 |
CID 6127. Segment Location in Lung ...................................................................................................................... |
|
808 |
CID 6128. Chest Distribution Descriptor .................................................................................................................. |
809 |
|
CID 6129. Chest Site Involvement .......................................................................................................................... |
|
809 |
CID 6130. Severity Descriptor ............................................................................................................................... |
|
810 |
CID 6131. Chest Texture Descriptor ....................................................................................................................... |
|
810 |
CID 6132. Chest Calcification Descriptor ................................................................................................................. |
811 |
|
CID 6133. Chest Quantitative Temporal Difference Type ............................................................................................ |
811 |
|
CID 6134. Chest Qualitative Temporal Difference Type .............................................................................................. |
811 |
|
CID 6135. Image Quality Finding ........................................................................................................................... |
|
812 |
CID 6136. Chest Types of Quality Control Standard ................................................................................................... |
812 |
|
CID 6137. Types of CAD Analysis .......................................................................................................................... |
|
813 |
CID 6138. Chest Non-lesion Object Type ................................................................................................................. |
813 |
|
- Standard -